MODIFICATIONS OF LOW-DENSITY-LIPOPROTEIN INDUCED BY ARTERIAL PROTEOGLYCANS AND CHONDROITIN-6-SULFATE

被引:56
作者
CAMEJO, G
HURT, E
WIKLUND, O
ROSENGREN, B
LOPEZ, F
BONDJERS, G
机构
[1] AB HASSLE ASTRA,CARDIOVASC RES LABS,GOTHENBURG,SWEDEN
[2] INST VENEZOLANO INVEST CIENT,CARACAS 1010A,VENEZUELA
关键词
PROTEOGLYCAN; GLYCOSAMINOGLYCAN; LOW DENSITY LIPOPROTEIN MODIFICATION; APOLIPOPROTEIN-B POLAR REGION; PROTEOLYSIS; THERMAL STABILITY;
D O I
10.1016/0925-4439(91)90013-Y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Association of low-density lipoproteins (LDL) with arterial chondroitin sulfate proteoglycans (CSPG) appears to contribute to their deposition in the extracellular intimal compartment and to its internalization by macrophages. CSPG and LDL interact by ionic bridges with formation of soluble and insoluble complexes. We studied the alterations on LDL structure induced by its association with arterial CSPG and other glycosaminoglycans (GAG). In soluble complexes, at low and at physiological ionic strength, arterial CSPG and sulfated GAG modify the kinetics of apoB-100 proteolysis by trypsin. However, less marked alterations in the peptide patterns were observed with proteinase V8 and almost none with thermolysin. This is indirect evidence that the presence of CSPG and GAG modified the exposure of polar regions of apoB-100 in LDL. Competitive binding experiments with agarose-bound heparin and soluble GAG also suggest that after formation of insoluble complexes with arterial CSPG and resolubilization the exposure of Lys, Arg-rich segments of apoB-100 is increased. Results from differential scanning calorimetry and differential thermal spectrophotometry showed that the CSPG and GAG-induced modifications reduced the thermal stability of the surface and core in LDL. If present in vivo, the structural alterations of polar segments of the LDL protein moiety may influence the outcome of its interaction with the arterial mesenchyma.
引用
收藏
页码:253 / 261
页数:9
相关论文
共 40 条
[1]  
AVIRAM M, 1988, J BIOL CHEM, V263, P16842
[2]  
BERENSON GS, 1988, ARCH PATHOL LAB MED, V112, P1002
[3]   STRUCTURE OF LOW-DENSITY LIPOPROTEIN IN COMPLEXES FORMED WITH ARTERIAL MATRIX COMPONENTS [J].
BIHARIVARGA, M ;
CAMEJO, G ;
HORN, MC ;
SZABO, D ;
LOPEZ, F ;
GRUBER, E .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1983, 5 (01) :59-62
[4]   INTERACTION OF LIPOPROTEIN LP(A) AND LOW-DENSITY LIPOPROTEIN WITH GLYCOSAMINOGLYCANS FROM HUMAN AORTA [J].
BIHARIVARGA, M ;
GRUBER, E ;
ROTHENEDER, M ;
ZECHNER, R ;
KOSTNER, GM .
ARTERIOSCLEROSIS, 1988, 8 (06) :851-857
[5]  
BONDJERS G, 1988, HYPERLIPIDEMIA ATHER, P135
[6]   IDENTIFICATION OF APO-B-100 SEGMENTS MEDIATING THE INTERACTION OF LOW-DENSITY LIPOPROTEINS WITH ARTERIAL PROTEOGLYCANS [J].
CAMEJO, G ;
OLOFSSON, SO ;
LOPEZ, F ;
CARLSSON, P ;
BONDJERS, G .
ARTERIOSCLEROSIS, 1988, 8 (04) :368-377
[7]  
CAMEJO G, 1982, ADV LIPID RES, V19, P1
[8]  
CAMEJO G, 1969, BIOCHIM BIOPHYS ACTA, V173, P290
[9]  
CAMEJO G, 1980, ATHEROSCLEROSIS, V67, P115
[10]   MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS [J].
CARDIN, AD ;
WEINTRAUB, HJR .
ARTERIOSCLEROSIS, 1989, 9 (01) :21-32